These results clarify the role of MYCN in cellular transformation and progression of MB, strengthening the hypothesis that MYCN drives the expansion and enrichment of CD133+ tumor-propagating cells capable of generating aggressive MB. This evidence concerns the gene MYCN and neoplasm.